Sort
53,477 grants matching “addiction”
Etiology of Sexual Risk, Substance Abuse, & Trauma; A Bioecological Systems Model
$626,017Laura L Otto-Salaj · University Of Wisconsin Milwaukee · R01 · FY2009 · DA
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior
$625,964Marcelo Andres Wood · University Of California-Irvine · R01 · FY2023 · DA
Micro-invasive biochemical sampling of brain interstitial fluid for investigating neural pathology
$625,925Robert S Langer · Massachusetts Institute Of Technology · R01 · FY2022 · EB
An Effectiveness Trial of Maintenance Therapy for Nicotine Dependence
$625,923Robert A Schnoll · University Of Pennsylvania · R01 · FY2011 · DA
Functions of Target-Defined Orbitofrontal Neuron Types in Decision Making
$625,816Adam Kepecs · Washington University · R01 · FY2024 · DA
Implementation, Outcomes, and Cost of a Novel Medicaid Policy to Reduce Opioids for Back Pain
$625,753Esther K Choo · Oregon Health & Science University · R01 · FY2020 · DA
Project 1 - Design and Synthesis of Novel Functionally Selective CB1 and CB2 Cannabinergic Ligands
$625,740Alexandros Makriyannis · Northeastern University · P01 · FY2024 · DA
Yappalli Choctaw Road To Health
$625,723Karina Lynn Walters · University Of Washington · R01 · FY2015 · DA
Cellular mechanisms of antidepressant drug actions in neuropathic pain models
$625,723Venetia Zachariou · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · NS
PET ligand development for mGlu2 based on negative allosteric modulators
$625,674Steven H Liang · Massachusetts General Hospital · R01 · FY2020 · MH
Effect of Bariatric Surgery on Insulin Resistance & CVD
$625,670Anita P Courcoulas · University Of Pittsburgh At Pittsburgh · U01 · FY2012 · DK
Regulation of Craving: Clinical Trial and Neural Mechanisms
$625,656Hedy Kober · Yale University · R01 · FY2021 · AA
In vivo prime editing for precision cancer mouse models
$625,607Wen Xue · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · CA
Delineating the role of serotonin 5-HT2 receptors in opioid use disorders:Development of novel 5-HT2 modulators with translational studies in rodents andprimates
$625,576Raymond G Booth · Northeastern University · R01 · FY2019 · DA
Mechanism Underlying Memory Stabilization
$625,560Cristina M Alberini · New York University · R01 · FY2014 · MH
Mechanism Underlying Memory Stabilization
$625,560Cristina M Alberini · New York University · R01 · FY2016 · MH
Mechanism Underlying Memory Stabilization
$625,560Cristina M Alberini · New York University · R01 · FY2015 · MH
Indigenous Strengths as Solutions in a Public Health Crisis (Project ISH)
$625,542Charene Alexander · Northwest Indian College · OT2 · FY2024 · DA
Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use
$625,386William Walton Stoops · University Of Kentucky · R01 · FY2017 · DA
Expanding Medication Assisted Therapies in Central Asia
$625,373Frederick Lewis Altice · Yale University · R01 · FY2022 · DA
Epigenetic mechanisms of sustained transcription across cocaine abstinence
$625,371Elizabeth A Heller · University Of Pennsylvania · R01 · FY2025 · DA
Small molecule modulators of ÎFosB
$625,300Gabrielle Rudenko · University Of Texas Med Br Galveston · R01 · FY2022 · DA
Translational approaches to TMS treatment development for smoking
$625,274Merideth A. Addicott · Wake Forest University Health Sciences · R01 · FY2021 · DA
Profiling DataBase for Cocaine Medications
$625,156Novascreen Biosciences Corporation · R44 · FY2003 · DA
Comparing Population Cessation Services with Emphasis on Unmotivated Smokers
$625,147James O Prochaska · University Of Rhode Island · R01 · FY2010 · DA